𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dipeptidyl Peptidase IV Inhibitors and the Incretin System in Type 2 Diabetes Mellitus

✍ Scribed by Alissa K. Langley; Terri J. Suffoletta; Heath R. Jennings

Book ID
115049581
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
143 KB
Volume
27
Category
Article
ISSN
0277-0008

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Type 2 diabetesβ€”Therapy with dipeptidyl
Type 2 diabetesβ€”Therapy with dipeptidyl peptidase IV inhibitors
✍ Hans-Ulrich Demuth; Christopher H.S. McIntosh; Raymond A. Pederson πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 803 KB

The sole application of an inhibitor of the dipeptidyl peptidase DP IV (also DP 4, CD26, DPP-IV or DPP-4) to a mammal subsequently leading to improved glucose tolerance marks a major breakthrough in metabolic research bearing the potential of a new revolutionary diabetes therapy. This was demonstrat